Xenon Pharmaceuticals shares fell 27.5% in the premarket after the company suspended new patient recruitment for depression drug trials.

Zhitongcaijing · 4d ago
Xenon Pharmaceuticals shares fell 27.5% in the premarket after the company suspended new patient recruitment for depression drug trials.